2002 News Release Archive

 
11/20/2002
Webster receives Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Diseases Research

Robert G. Webster, Ph.D., F.R.S., has been selected to receive the Twelfth Annual Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Diseases Research ...

 
 
11/14/2002
Immunologic "bait and switch" may be key to treating autoimmune disease and improving outcome of organ and tissue transplantation

Researchers at St. Jude Children's Research Hospital have demonstrated that it may be possible to improve treatment of autoimmune diseases like multiple sclerosis and prevent rejection of transplanted organs and tissues.

 
 
10/18/2002
St. Jude faculty elected to Institute of Medicine

Arthur Nienhuis, M.D., and William Evans, Pharm.D., of St. Jude Children's Research Hospital have been elected to the Institute of Medicine, a prestigious branch of the National Academy of Sciences.

 
 
10/15/2002
St. Jude to receive multi-million dollar grant for sickle cell program

St. Jude Children's Research Hospital has competed for and will receive a multi-million dollar, five-year grant to expand its sickle cell disease program.

 
 
10/02/2002
St. Jude scientists discover role of c-Myc gene in tumor development

Researchers discovered that the c-Myc gene is essential for tumor development. They found that c-Myc is essential for the production and growth of blood vessels into tumors. Researchers were able to use this information to cut off the blood supply to tumors and thwart tumor growth.

 
 
08/30/2002
St. Jude study shows motor protein prestin is critical for mammals' hearing

Scientists have discovered that prestin, a cell membrane protein, is the motor protein that allows sound amplification crucial to mammalian hearing.

 
 
08/26/2002
Nature Medicine touts Webster's latest discovery

St. Jude researchers have been tracking a killer strain of influenza and have identified the strategy it used to slay its victims. A team of scientists discovered a protein that helps the virus avoid infection-fighting proteins produced by the body.

 
 
07/02/2002
The best of the best - St. Jude researcher receives prestigious American Cancer Society grant

Ching-Hon Pui, M.D., of St. Jude Children's Research Hospital, has been named an American Cancer Society Clinical Research Professor.

 
 
07/02/2002
William Evans, Pharm. D., named St. Jude Scientific Director

William Evans, Pharm.D., will assume the newly created position of scientific director at St. Jude Children's Research Hospital Aug. 1.

 
 
06/25/2002
St. Jude researchers prove mesenchymal cell infusions enhance effects of bone marrow transplant for children with brittle bone disease

Treatment with bone marrow mesenchymal cells, specialized bone-making cells, has the potential to enhance the therapeutic effects of bone marrow transplantation in patients with osteogenesis imperfecta (OI), also known as brittle bone disease.

 
 
05/31/2002
Gene-therapy advances offer hope to chemotherapy patients

Recent advances in the design of gene-therapy vectors offer promise for cancer patients who must receive chemotherapy, according to an article published in Nature Reviews Cancer.

 
 
05/31/2002
Bone marrow transplantation does not improve outcome in babies with high-risk acute lymphoblastic leukemia

Researchers discovered that infants treated for acute lymphoblastic leukemia (ALL) whose leukemic cells have a 11q23 chromosomal abnormality do not benefit from bone marrow transplantation. Research indicates that physicians treating these patients should rely on improved chemotherapy.

 
 
05/17/2002
Genetic link discovered between two inherited rare diseases that each cause cancer in children

Interactions between the genes mutated in two different rare inherited disorders, Fanconi Anemia and Ataxia-Telangiectasia, provide new insights into tumor development and responses of tumors to therapy.

 
 
05/02/2002
Rabbit liver protein provides clues to improving cancer therapy

A rabbit liver protein can effectively activate the promising anti-cancer drug CPT-11, according to scientists at St. Jude Children's Research Hospital.

 
 
03/27/2002
New diagnostic tool means better treatment for pediatric leukemia

St. Jude researchers unveiled a genetic screening technique using microarray chops that should lead to dramatic improvements in diagnosing and treating ALL, and could lead to higher cure rates. The test is more than 95 percent accurate in diagnosing the known ALL subtypes and can identify new prognostic information.

 
 
03/08/2002
Long-elusive mutant mouse gene found: a link between nerve degeneration, regeneration

A defective gene responsible for the death of nerve cells in the adult brain of mice has been identified, according to a study led by scientists at St. Jude Children's Research Hospital.

 
 
02/28/2002
Acute myeloid leukemia "model" may be important research tool for many cancer treatments

A method that enables scientists to study the development of an acute myeloid leukemia (AML) in mice should open new research paths for scientists studying cancer in humans.

 
 
01/29/2002
Seriously ill kids put up defenses to hide depression

Children with cancer and other serious illnesses often adapt to their conditions by repressing their emotions and covering up feelings of depression and anxiety, according to a new study published in January's Psychosomatic Medicine.

 
 
01/08/2002
Effect of radiation on normal brain identified in a landmark study of children with brain tumors

The effect of radiation on a child's brain has been measured for the first time in a pioneer study of pediatric brain tumor patients.

 
Email This Article Email This Article   |   Print Print